Self-monitoring Blood Glucose (SMBG): Now and the Future

Journal of Pharmacy Practice

Volumn 17, Issue 1, 2004, Pages 29-38

  Briggs, Amber L ^a,b   Cornell, Susan ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b Dominick's Pharmacy ^*  (United States)

Author keywords

Blood glucose; Diabetes; Meters; Self monitoring blood glucose

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; AMYLASE INHIBITOR; BIGUANIDE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; SULFONYLUREA DERIVATIVE;

ACCURACY; AMPEROMETRY; BLOOD GLUCOSE MONITORING; CALIBRATION; COMPUTER PROGRAM; COST OF ILLNESS; DEVICE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIET THERAPY; DRUG DOSE REGIMEN; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; INSULIN TREATMENT; MEASUREMENT; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MONITOR; PATIENT CARE; PATIENT EDUCATION; PHARMACIST; PHOTOMETRY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; SELF MONITORING; TECHNIQUE;

EID: 1642579601     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190003261306     Document Type: Review

References (52)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:S5-S20.
2. National Diabetes Information Clearing House: A Service of National Institute of Diabetes and Digestive and Kidney Disease. National diabetes statistics. NIH Web site. Retrieved August 17, 2003, from http://diabetes.niddk.nih.gov/dm/pubs/statistics/.
3. American Diabetes Association Position Statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26:S33-S50.
4. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKFDS 33), Lancet, 1998;352:837-853.
5. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993;329:977-986.
6. American Association of Clinical Endocrinologists. Diabetes guidelines. Endocr Pract. 2002;8(supp 1):41-65.
7. Weiner JP, Parente ST, Garnick DW, et al. Variation in office based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA. 1995;273:1503-1508.
8. Glascow RE, Boles SM, Calder D, et al. Diabetes care practices in primary care: results from two samples and three measurement sets. Diabetes Educ. 1999;25:755-763.
9. American Diabetes Association. Testing of glycemia in diabetes. Diabetes Care. 2003;26:S106-S108.
10. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979-982.
11. Franciosi M, Pellegrini F, De Berardis G, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care. 2001;24:1870-1877.
12. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA. 2002;287:360-372.
13. Cornell S. Self-monitoring blood glucose monitor update. Advances in Pharmacy. 2003;1:106-111.
14. Demers J, Kane MP, Bakst G, et al. Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus OneTouch Ultra. Am Health-Syst Pharm. 2003;60:1130-1135.
15. Nettles A. User error in blood glucose monitoring. Diabetes Care. 1993;16:946-948.
16. Skeie S, Thue G, Nerhus K, et al. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem. 2002;48:994-1003.
17. Ascensia Breeze™ Blood Glucose Monitoring System [user guide]. Mishawaka, IN: Bayer HealthCare LLC; 2003.
18. Ascensia Dex2™ Diabetes Care System [user guide]. Mishawaka, IN: Bayer HealthCare LLC; 2002.
19. Ascensia Elite XL™ Diabetes Care System [user guide], Mishawaka, IN: Bayer HealthCare LLC; 2002.
20. OneTouch Ultra™ Blood Glucose Monitoring System [owner's booklet], Milpitas, CA: LifeScan, Inc; 2000,
21. Accu-Chek Advantage™ Blood Glucose Monitoring System [user's manual]. Indianapolis, IN: Roche Diagnostics Corporation; 2001.
22. Accu-Chek Active™ Blood Glucose Monitoring System [user's manual]. Indianapolis, IN: Roche Diagnostics Corporation; 2001.
23. Accu-Chek Compact™ Blood Glucose Monitoring System [user's manual]. Indianapolis, IN: Roche Diagnostics Corporation; 2001.
24. Freestyle™ Blood Glucose Monitoring System [owner's booklet]. Alameda, CA: TheraSense, Inc; 2002.
25. OneTouch UltraSmart™ Blood Glucose Monitoring System [owner's booklet]. Milpitas, CA: LifeScan, Inc; 2002.
26. Accu-Chek Advantage™ Blood Glucose Monitoring System [owner's booklet user's manual]. Indianapolis, IN: Roche Diagnostics Corporation; 2001.
27. LifeScan, Inc. Frequently asked questions about alternative site testing. Life Scan report AW057-633. Milpitas, CA: LifeScan, Inc; 2002.
28. American Diabetes Association, Self-monitoring of blood glucose. Diabetes Care. 1994;18:81-86,
29. Adams AS, Mah C, Soumerai SB, et al. Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study, BMC Health Serv Res. 2003;3:6.
30. Accu-Chek™. Products. Retrieved August 31, 2003, from http://www.accu-chek.com/products/maincfm.
31. TheraSense. FreeStyle Tracker™. Retrieved August 28, 2003, from http://www.therasensecom/tracker/index.asp.
32. McGarraugh G, Price D, Schwartz S, Weinstein R. Physiological influences on off-finger glucose testing. Diabetes Technol Ther. 2001;3:367-373.
33. Berlin I, Bisserbe JC, Eiber R, et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care. 1997;20:176-178.
34. Lock JP, Szuts EZ, Malomo KJ, Anagnostopoulos A. Whole-blood glucose testing at alternative sites. Diabetes Care. 2002;25:337-341.
35. Jungheim K, Koschinsky T. Risky delay of hypoglycemia detection by glucose monitoring at the arm. Diabetes Care. 2001;24:1303-1304.
36. McGarrugh G. Response to Jungheim and Koschinsky. Diabetes Care. 2001;24:1304-1305.
37. Ellison JM, Stegmann JM, Colner SL, et al. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care. 2002;25:961-964.
38. Bennion N, Christensen NK, McGarraugh G. Alternative site glucose testing: a crossover design. Diabetes Technol Ther. 2002;4:25-33.
39. LifeScan, Inc. Abbreviated procedure guide. Life Scan report AW057-845A. Milpitas, CA: LifeScan, Inc; 2002.
40. Ginsberg BH. The FDA reevaluates alternative site testing for blood glucose. Diabetes Technol Ther. 2002;4:347-349.
41. LifeScan, Inc. Ease of use of the OneTouch UltraSmart Blood Glucose Monitoring System by patients with diabetes. LifeScan report AW058-875A. Milpitas, CA: LifeScan, Inc; 2003.
42. BD Latitude Diabetes Management System. Retrieved August 21, 2003, from http://www.bddiabetes.com/us/bgm/latitude_product.jsp.
43. MedTronic Minimed CGMS System Gold Product Information. Retrieved August 23, 2003, from http://www.minimed.com/patientfam/pf_products_cgms_ov_completepic.shtml.
44. Gross TM, Bode BW, Einhorn D, et al. Performance evaluation of the MiniMed Continuous Glucose Monitoring System during patient home use. Diabetes Technol Ther. 2000;2:49-56.
45. Monsod TP, Flanagan DE, Rife F, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;5:889-893.
46. Metzger M, Leibowitz G, Wainstein J, et al. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care. 2002;25:1185-1191.
47. Chase HP, Kim LM, Owen SL, et al. Continue subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics. 2001;107:222-226.
48. The GlucoWatch G2 Automatic Glucose Biographer. Product information. Retrieved August 23, 2003, from http:// www.glucowatch.com/us/professional/index.html.
49. Potts RO, Tamada JA, Tierney MJ, Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev. 2002;18(suppl 1):S49-S53.
50. Garg SK, Potts RO, Ackerman NR, et al. Correlation of fingerstick blood glucose measurements with GlucoWatch Biographer glucose results in young subjects with type 1 diabetes. Diabetes Care. 1999;22:1708-1714.
51. Larin KV, Eledrisi MS, Motamedi M, et al. Noninvasive blood glucose monitoring with optical coherence tomography. Diabetes Care. 2002;25:2263-2267.
52. Malchoff CD, Shoukri K, Landau JL, et al. A novel noninvasive blood glucose monitor. Diabetes Care. 2002;25:2268-2275.